Applied DNA Sciences, Inc. (APDN)
USD 0.23
(1.26%)
USD 0.23
(1.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.21 Million | -8.97 Million | -13.38 Million | -11.14 Million | -6.86 Million | -6.91 Million |
| Net Income | -10.02 Million | -8.27 Million | -14.27 Million | -13.02 Million | -8.63 Million | -11.69 Million |
| Depreciation & Amortization | 1.36 Million | 1.29 Million | 844.43 Thousand | 285.73 Thousand | 390.42 Thousand | 547.79 Thousand |
| Deferred income taxes | 684.11 Thousand | - | - | 45.28 Thousand | 1.26 Million | 20.55 Thousand |
| Stock-based compensation | 1.03 Million | 2.51 Million | 1.66 Million | 1 Million | 1.12 Million | 1.35 Million |
| Change in working capital | 2.44 Million | 954.56 Thousand | -3.61 Million | 527.73 Thousand | 680.82 Thousand | 2.84 Million |
| Other non-cash items | -1.72 Million | -5.47 Million | 1.99 Million | 26.01 Thousand | -1.69 Million | 1479.00 |
| Investing Cash Flow | -1.09 Million | -489.55 Thousand | -2.54 Million | -1.06 Million | -67.43 Thousand | -266 Thousand |
| Investments in PPE | -78.44 Thousand | -489.55 Thousand | -2.54 Million | -1.06 Million | -67.43 Thousand | -266 Thousand |
| Acquisitions | -1.06 Million | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 45 Thousand | - | - | - | - | - |
| Financing Cash Flow | - | 18.12 Million | 14.7 Million | 19.43 Million | 5.82 Million | 5.88 Million |
| Debt repayment | - | - | -1.66 Million | -107.8 Thousand | -1.98 Million | -1.65 Million |
| Dividends payments | - | -110.1 Thousand | - | - | - | - |
| Common Stock Repurchased | 952.5 Thousand | - | - | - | - | - |
| Common Stock Issuance | - | 14.42 Million | 16.37 Million | 10.63 Million | 3.85 Million | 4.23 Million |
| Other Financing Activities | - | 3.81 Million | 16.37 Million | 8.9 Million | 3.84 Million | 1.65 Million |
| Accounts receivables | 3.05 Million | -532.95 Thousand | -2.63 Million | 600.35 Thousand | 638.33 Thousand | 1.08 Million |
| Accounts payables | -1.35 Million | 930.49 Thousand | 125.12 Thousand | 400.07 Thousand | 691.66 Thousand | 158 Thousand |
| Inventory | 272.21 Thousand | 767.68 Thousand | -872.56 Thousand | -354.73 Thousand | 78.74 Thousand | 105.09 Thousand |
| Other working capital | 474.69 Thousand | -210.66 Thousand | -230.03 Thousand | -117.95 Thousand | -727.92 Thousand | 1.5 Million |
| Cash at beginning of period | 15.21 Million | 6.55 Million | 7.78 Million | 558.98 Thousand | 1.65 Million | 2.95 Million |
| Cash at end of period | 7.9 Million | 15.21 Million | 6.55 Million | 7.78 Million | 558.98 Thousand | 1.65 Million |
| Capital Expenditure | -78.44 Thousand | -489.55 Thousand | -2.54 Million | -1.06 Million | -67.43 Thousand | -266 Thousand |
| Effect of forex changes on cash | -952.5 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -7.31 Million | 8.66 Million | -1.23 Million | 7.22 Million | -1.1 Million | -1.3 Million |
| Free Cash Flow | -6.29 Million | -9.46 Million | -15.93 Million | -12.2 Million | -6.92 Million | -7.18 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.87 Million | -4.47 Million | -1.13 Million | -10.02 Million | -3.61 Million | -3.11 Million |
| Depreciation & Amortization | 134.16 Thousand | 186.32 Thousand | 298.95 Thousand | 1.36 Million | 329.68 Thousand | 349.14 Thousand |
| Deferred income taxes | - | - | 628.05 Thousand | 684.11 Thousand | 684.11 Thousand | - |
| Stock-based compensation | 30.33 Thousand | 171 Thousand | 340.7 Thousand | 1.03 Million | 341.49 Thousand | 340.04 Thousand |
| Change in working capital | -348.66 Thousand | 30.49 Thousand | -628.05 Thousand | 2.44 Million | 767.59 Thousand | 681.24 Thousand |
| Other non-cash items | -4.48 Million | 1.28 Million | -3.26 Million | -1.72 Million | -1.18 Million | 374.56 Thousand |
| Investing Cash Flow | -21.82 Thousand | -14.82 Thousand | - | -1.09 Million | -924.66 Thousand | -161.8 Thousand |
| Investments in PPE | -21.82 Thousand | -14.82 Thousand | - | -78.44 Thousand | 117.07 Thousand | -161.8 Thousand |
| Acquisitions | - | - | - | -1.06 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 45 Thousand | -1.04 Million | -137.6 Thousand |
| Financing Cash Flow | 10.8 Million | 3.01 Million | -35.07 Thousand | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | -77.75 Thousand | - | - | - |
| Common Stock Repurchased | - | - | - | 952.5 Thousand | 952.5 Thousand | - |
| Common Stock Issuance | 10.8 Million | 2.93 Million | 45.56 Thousand | - | - | - |
| Other Financing Activities | 10.8 Million | 80.64 Thousand | -2885.00 | - | - | - |
| Accounts receivables | -105.01 Thousand | 41.9 Thousand | -195.25 Thousand | 3.05 Million | 410.38 Thousand | 1.25 Million |
| Accounts payables | -163.57 Thousand | 51.32 Thousand | -383.42 Thousand | -1.35 Million | -720.13 Thousand | -651.84 Thousand |
| Inventory | -133.92 Thousand | 41.34 Thousand | -47.26 Thousand | 272.21 Thousand | -53.6 Thousand | 89.66 Thousand |
| Other working capital | 53.85 Thousand | -104.08 Thousand | -2113.00 | 474.69 Thousand | 1.13 Million | -7413.00 |
| Cash at beginning of period | 3.14 Million | 3.35 Million | 7.9 Million | 15.21 Million | 11.5 Million | 13.03 Million |
| Cash at end of period | 10.44 Million | 3.14 Million | 4.1 Million | 7.9 Million | 7.9 Million | 11.5 Million |
| Capital Expenditure | -21.82 Thousand | -14.82 Thousand | - | -78.44 Thousand | 117.07 Thousand | -161.8 Thousand |
| Effect of forex changes on cash | - | - | - | -952.5 Thousand | -952.5 Thousand | - |
| Net cash flow / Change in cash | 7.29 Million | -209.4 Thousand | -3.79 Million | -7.31 Million | -3.6 Million | -1.53 Million |
| Free Cash Flow | -3.51 Million | -3.22 Million | -3.75 Million | -6.29 Million | -2.56 Million | -1.53 Million |
TARACHAND
7836
CIFL
5452
CHCO
3288